Sexual Health Texting Intervention to Support Adolescent Females
Effectiveness of a Patient Centered Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Disease Among Adolescents
1 other identifier
interventional
244
1 country
1
Brief Summary
This study aims to use a text messaging intervention to prevent unintended teen pregnancy and transmission of sexually transmitted disease. The study will be informed by a formative qualitative phase (February 2014 - January 2015) which will include individual qualitative interviews and focus groups with teens to elucidate and explore the barriers to effective contraceptive use and sexually transmitted disease (STD) prevention and to obtain feedback on the developed intervention. The second efficacy phase will randomize subjects to the texting intervention or to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedResults Posted
Study results publicly available
November 10, 2020
CompletedNovember 10, 2020
September 1, 2020
1.8 years
January 13, 2015
September 18, 2020
October 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Dual Protection Behaviors, Reported in Surveys and Reviewed in the Medical Record.
Practice of protection from STIs and unintended pregnancy were reported at baseline and follow up surveys. Between-group differences at baseline, 3 and 6-month follow-up among participants with data at all points AND who were sexually active at baseline were analyzed.
6 months
Secondary Outcomes (3)
Use of the Most Effective Contraception Methods: Long Acting Reversible Contraceptives (LARCs)
6 months
Knowledge, Motivation, and Attitudes Toward Contraception, Condom Use and Dual Protection in Surveys
6 months
Unprotected Vaginal Sex at Baseline, 3 and 6 Months Post-baseline (Formerly Incidence of Unintended Pregnancy and STIs)
6 months
Study Arms (2)
Usual Care
NO INTERVENTIONThe current standard of care in the clinic is a preventive care physical examination every 1-2 years and/or treatment for presenting medical conditions. The frequency and content of reproductive health is not standardized between clinicians, but it is expected that all clinicians will address sexuality during routine visits. Additionally, sexually active teens are encouraged to have urine screening tests for chlamydia, gonorrhea and pregnancy as indicated. Teens may also see a reproductive health educator at the clinic as well. Available contraceptive methods are oral contraceptive pills, contraceptive patches, Depo-Provera, diaphragms, condoms, implants and intrauterine devices (IUDs).
text message intervention
ACTIVE COMPARATORSubjects in the intervention arm will receive usual care plus text messages that have been developed to promote overall teen sexual health.
Interventions
Subjects will be sent 58 messages (3-5 per week) over 12 weeks, plus reminder messages for follow up interviews. The content of these messages will focus on contraception methods and effectiveness, sexually transmitted infection (STI) transmission, condom use, partner and parental communication, and healthy relationships. There will also be several text messages asking the participant if they would like to have a health educator contact them. The format will include facts, quizzes, true/false and some will have links to videos/pictures and websites, and some will request a response.
Eligibility Criteria
You may qualify if:
- biologically female;
- between 13 and 18 years of age;
- not currently pregnant or trying to become pregnant;
- have texting capability; and
- able to read/write/speak in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Denver Health
Denver, Colorado, 80204, United States
Limitations and Caveats
Data are self-report and thus may be influenced by social desirability and/or recall. Unable to assess 6-month STI and pregnancy incidence. Limited ability to detect significance due to heterogeneous sample and lack of power in stratified analyses.
Results Point of Contact
- Title
- Deborah Rinehart
- Organization
- Denver Health & Hospital Authority
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Rinehart, PhD
Denver Health and Hospital Authority
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Research Scientist
Study Record Dates
First Submitted
January 13, 2015
First Posted
April 17, 2015
Study Start
April 1, 2015
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
November 10, 2020
Results First Posted
November 10, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share